Evonik starts Medical Devices Project House in USA
Eleventh project house of the specialty chemicals company will focus on growth market of medical technology
BS B2B Bureau B2B Connect | Essen, Germany
Dr Peter Nagler, Chief Innovation Officer at Evonik, said, “In the new Medical Devices Project House, we are pooling and expanding the interdisciplinary competencies of Evonik in the area of medical technology and biomaterial research. By locating it in the USA, we are continuing to internationalise our R&D activities." The specialty chemicals company already started the Light & Electronics Project House in Taiwan in the year 2011.
"We want to open up new growth opportunities for Evonik in the medical technology market with innovative products," says Nagler. The global medical technology market with a volume of Euro 300 billion is posting annual growth rates of 6%. At 40%, the USA accounts for a major proportion of this world market and US companies hold leading positions, above all in the area of implantology.
More From This Section
The work areas addressed by the Medical Devices Project House are closely focused on current and future customer needs in the area of medical technology. "Innovative solutions in medical technology, such as functional biomaterials, are excellently suited for meeting the demand for ever-more compatible and safer medical products and for implementing new therapeutic concepts," explains Dr. Rosario Lizio, who heads the Medical Devices Project House.
Also Read
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Apr 05 2014 | 12:23 PM IST